ThomasJosephReidIIIMDPhD FACP

Oncology • Cody, WY

Breast Cancer, Gastrointestinal Cancer, Head & Neck Cancer, Hematologic Oncology

Medical Director, Big Horn Basin Cancer Center

Join to view full profile

Dr. Reid is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Reid's full profile

Already have an account?

Office
1025 9th St
Cody, WY 82414
Phone+1 307-578-2828

Fax+1 307-578-2828

Summary

Dr. Thomas Reid is Medical Director of the Regional Cancer Center and Chief of Hematology-Medical Oncology at Memorial Hospital of South Bend in South Bend, Indiana; specializing in the practice of Hematology-Medical Oncology.

He is originally from Harrisburg, PA. He earned his BS in Microbiology at The Pennsylvania State University (1976) and his PhD in Biochemistry at Purdue University (1981). He earned his MD at the Uniformed Services University of the Health Sciences in Bethesda, MD (1985). He completed his internship (1986) and residency (1988) in Internal Medicine and fellowship in Hematology-Medical Oncology (1991) at the Walter Reed Army Medical Center, Washington, DC.

From 1991 to 2004, he was at the Walter Reed Army Institute of Research; Chief of Blood Research for the last 3 of those years. There, his primary research interests were extended storage of blood products, blood substitutes, and coagulation disorders. From 2004 to 2008 he was Chief of Hematology-Medical Oncology at the Walter Reed Army Medical Center. As Chief, he also served as Chair of the Cancer Care Committee, Co-Chair of the Institutional Review Board and Principal Investigator for Cancer and Leukemia Group B (a cooperative group for cancer clinical trials). After 27 years in the Army Medical Corps, he retired in 2008 as a full Colonel. From July 2008 and June 2011, he was in private practice. From 2011 to 2012, he was Chief, Hematology-Medical Oncology and Oncology Program Director at MedStar Good Samaritan and MedStar Union Memorial Hospitals in Baltimore, MD. During that period he also served as Co-Chair of the Clinical Research Committee at the Lombardi Cancer Center, Georgetown University Medical Center.

He is married to Joy and has two sons: Christopher and Tristan.

Education & Training

National Capital ConsortiumFellowship, Hematology and Medical Oncology, 1988 - 1991
National Capital ConsortiumResidency, Internal Medicine, 1986 - 1988
National Capital ConsortiumInternship, Internal Medicine, 1985 - 1986
Uniformed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 1985
Purdue UniversityPh.D, Protein Crystallography/Biochemistry, 1976 - 1981
The Pennsylvania State UniversityB.S, Microbiology/Chemistry, 1972 - 1976

Certifications & Licensure

WY State Medical License 2020 - 2025
MD State Medical License 2011 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Hope Award American Cancer Society, 2014
CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011
Proficiency Designator US Army, 1999
Graduate cum Laude Penn State U
Grant Recipient Purdue U
Alpha Omega Alpha Honor Society USUHS
Fellow American College of Physicians
Join now to see all

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
Active, not recruiting
Phase 3
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Start of enrollment: 2011 Jan 24
Active, not recruiting
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
Active, not recruiting
Phase 3
Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax Start of enrollment: 2013 May 21
Completed
Phase 2
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery Start of enrollment: 2012 Aug 08
Active, not recruiting
Phase 3
Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme Start of enrollment: 2012 Nov 01
Completed
Phase 1, Phase 2
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer Start of enrollment: 2013 Jul 08
Completed
Phase 2
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery Start of enrollment: 2013 Aug 01
Active, not recruiting
Not Applicable
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2013 Dec 09
Active, not recruiting
Phase 3
Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
No longer available
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08
Completed
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) Start of enrollment: 2015 Feb 11
Active, not recruiting
Phase 3
Dabrafenib and Trametinib for the Treatment of Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2014 Sep 19
Active, not recruiting
Phase 2
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

5 citations
Sideroblastic anemia, iron overload, and ALAS2 R452S in African-American males: phenotype and genotype features of five unrelated patients.
Pauline Lee, Thomas J. Reid, Sylvia S. Bottomley, James C. Barton
American Journal of Hematology. 2011-09-01
18 citations
Optical density values correlate with the clinical probability of heparin induced thrombocytopenia.
Brendan M. Weiss, Nathan M. Shumway, Robin S. Howard, Lloyd K. Ketchum, Thomas J. Reid
Journal of Thrombosis and Thrombolysis. 2008-12-01
60 citations
Massive transfusion and nonsurgical hemostatic agents.
Jeremy G. Perkins, Andrew P. Cap, Brendan M. Weiss, Thomas J. Reid, Charles E. Bolan
Critical Care Medicine. 2008-07-01

Journal Articles

Update: Managing patients with venous thrombosis.
Reid TJ, Alving BM, Intern Med;14:48-58
Bilateral synchronous testicular germ cell cancer.
Redmond III J, Samaha MA, Charles RS, Vuke1ja SJ, Faragher D, Tenglin R, Reid T, Dawson N, Auerbach H, Richter M, South Med J; 88:305-8
Etoposide (VP-16) and cisplatin at maximum tolerated dose in non-small cell lung carcinoma: a Cancer and Leukemia Group B study.
Muscato JJ, Cirrincione C, Clamon G, Perry MC, Omura G, Berkowitz I, Reid T, Herndon JE, Green MR, Lung Cancer;13:285-94
Exposure of human CD34+ cells to HIV I does not influence their expansion and proliferation of hematopoietic progenitors in vitro.
Kaushal S. La Russa VF, Gartner S, Kesler S, Perfetto S, Yu Z, Ritchey DW, Xu J. Perera P, Kim J, Reid TJ, Mayers DL, Louis D and Mosca JD, Blood; 88:130-7
Cryopreservation of human platelets.
Reid TJ, Gao D, Cryobiology; 38:177-179
Development of optimal technology for cryopreservation of human platelets I: Platelet activation during cold storage (at 22oC and 8oC) and cryopreservation processes.
Gao DY, Neff K, Cui XD, Bonderman P, Harvey K, Matsubayashi H, McIntyre JA, Critser J, Miraglia CC, Reid TJ, Cryobiology; 38:225-35
Preliminary evaluation of some hemostatic parameters in dengue patients.
Krishnamurti CK, Kalayanarooj S, Asher L, Cutting MA, Peat RA, Rothwell SW, Reid TJ, Green S, Nisalak A, Vaughn DW, Nimmannitya S, Innis BL, Amer. J. Trop. Med. Hyg;59:158-159
Effects of high molecular weight cryoprotectants on platelets and the coagulation system.
Bakaltcheva I, Ganong J, Holtz B, Peat R, Reid TJ, Cryobiology; 40:283-93
Generation of annexin-V positive platelets and shedding of microparticles with stimulus-dependent procoagulant activity during storage of platelets at 4oC.
Xiao HY, Matsubayashi H, Bonderman DP, Bonderman PW, Reid TJ, Miraglia CC, Gao DY, Transfusion; 40:420-7
Effects of -tocopherol on platelets and the coagulation system.
Bakaltcheva I, Gyimah D, Reid TJ, Platelets; 12:389-94
Effect of taurine on platelets and the plasma coagulation system.
Miglis M, Wilder D, Reid TJ, Bakaltcheva I, Platelets;13:5-10
The association of dimethylsulfoxide and model membranes studied by pulse-field gradient NMR.
Kennedy A, Long C, Hmel PJ, Hicks R, Reid TJ, Spectroscopy;18:265-9
Join now to see all

Books/Book Chapters

The Biological Chemistry of Iron.
Chapter: The Three Dimensional Structure of Beef Liver Catalase
Murthy MRN, Reid TJ, Sicignano A, Tanaka N. Rossmann MGEditors: HB Dunford et al.D Reidel Publishing Co, New York

Abstracts/Posters

White particulate matter found in Terumo blood collection bags consisted of mostly platelets and white blood cells.
Rentas FJ, Macdonald VM, Rothwell S, McFaul S, Asher LV, Kennedy A, Hmel P, Meledandri C, Salata J, Harman R, Reid T, AABB Transfusion;43 (Supplement):62A(SP67)
Correlation of in vivo and in vitro function of fresh and stored human platelets.
Rothwell SR, Maglasang P, Reid TJ, Gorogias M, Krishnamurti C, Blood; 94(Suppl 1):462a
Effectiveness of fibrin and collagen dressings in porcine femoral artery injury model.
Taher M, Park R, Reid TJ, 7th International Veterinary Emerg and Crit Care:797
Effects of Propyl Gallate and -amino caproic acid additives on fibrin bandage performance.
Rothwell SW, Fudge JM, Reid TJ, Krishnamurti C, ISTH 2001
Trauma-Associated Coagulopathy.
Peat RA, Holtz BL, Morrissette CR, Ketchum LH, Reid TJ, Blood; 98(11; Part 2):109b
Physical and Thermal Properties of Blood Storage Bags – Implications for Shipping Frozen Products on Dry Ice.
Hmel PJ, Kennedy AM, Quiles JG, Gorogias M, Seelbaugh JP, Reid TJ, Blood; 98(11; Part2):109b
Efficacy of Hemostatic Dressings with Salmon Thrombin and Fibrinogen in a Rat Hip Penetrating Injury Model.
Fuller ET, Janmey PA, Sawyer ES, Fudge JM, Mochmer KL, Peat PA, Seelbaugh JP, Reid TJ, Blood; 98(11; Part 2):76b
Lyophilization of blood cells.
Bakaltcheva I, Reid TJ, International Society of Lyophilization
Lack of PF3 activity in solvent/detergent treated plasma.
Gilstad CW, Ketchum LH, Hmel PJ, Gorogias M, Kennedy AM, Sandler SG, Reid TJ, International Society for Blood Transfusion
Characterization of membrane transitions using nuclear magnetic resonance techniques.
Kennedy A, Hmel PJ, Reid TJ, 23rd U.S. Army Research Conference
Increased storage capability of red blood cells during contingency operations.
Rentas FJ, Macdonald VW, Reid TJ, 23rd U.S. Army Research Conference
Lyophilized blood cells.
Bakaltcheva I, Macdonald VW, Rothwell SR, Fisher T and Reid TJ, 23rd U.S. Army Research Conference
Effects of Antifreeze Proteins, Artificial Ice Blockers and Ice Nucleating Bacteria on Blood Coagulation.
Bakaltcheva I, Tsonev L, Hmel PJ, Reid TJ, Annual Meeting Society for Cryobiology, Cryobiology;45:245(#72)
Development of Lyophilization Protocols for Blood Cells.
Bakaltcheva I, Macdonald VW, Steve Rothwell SW, Fisher T, Thomas Reid TJ, Annual Meeting Society for Cryobiology, Cryobiology;45:249(#80)
Catastrophic failures of freezing bags for cellular therapy products. Investigation of the molecular origin by positron annihilation lifetime spectroscopy.
Merchant P, Donaghy JJ, Hmel PJ, Khuu HM, Carter CS, Read EJ, Reid TJ, Van Ness KE, ISCT
An Iceless container capable of keeping red blood cells at 1-10oC in austere environments for over 78 hours.
Rentas FJ, Houchens DM, Macdonald VM, Wallace MW, Mayer W, Reid TJ, AABBTransfusion ;43 (Supplement):56A(SP46)
Clotting times and platelet induced clot retraction of human plasma and platelets: Comparison of thrombin derived from different animal species and implications for no...
Gorogias M, Reid TJ, Blood; 94(Suppl 1):88b
Post-thaw storage unaffected by the use of different plastic bags for freezing red blood cells.
Rentas FJ, Colon AF, Lippert LE, Salata J, Harman J, Childs J, McFaul S, Reid TJ, AABB Transfusion; 43 (Supplement):68A(SP89)
Inactivation of Orientia tsutsugamuchi in an animal model using the INTERCEPT blood system for platelets.
Rentas FJ, Lippert L, Harman R, Gomez C, Salata J, Childs J, Silva T, Chan C, Jiang J, Dupuis K, Reid T, Sawyer L, AABB Transfusion; 43 (Supplement):84A(SP141)
Formation of Blood Clots: Relative Contributions of Platelets and Red Blood Cells to Clot Formation and Clot Strength.
Weiss BM, Hmel PJ, Long CJ, Ketchum LH, Reid TJ, ASH Blood; 102(11; Part 2):76b (#4008)
Hematology Consultation Along with Clinical Scores by the 4 Ts Improves the Evaluation and Management of Heparin Induced Thrombocytopenia.
Shumway NM, Weiss BM, Ketchum LH, Reid TJ, Blood;101(11):828a #3031
Response to High Dose (HD) Imatinib Therapy in Relapsed c-kit+ Acute Myeloid Leukemia (AML).
Buda EM, Cruser DL, Weiss BM, Van Echo DC, Alvarez GC, Reid TJ, Blood;101(11):216b #4532
Walter Reed Army medical Center experience in treatment of hemorrhagic shock with recombinant Factor VIIa.
Cap AP, Reid TJ, ACP Annual Meeting,
Warfarin Resistance.
Marte, M, Reid TJ, ACP Annual Meeting
A Bronchial Indolent Lymphoma Associated with Sjogren’s Syndrome Responds to Treatment with Rituximab: A Case Report.
Betteridge JD, Reid TJ, ACP Annual Meeting
Join now to see all

Lectures

Hemostasis and Blood Products for Combat Casualty Care.
Multiple locations, 2004
Represented DoD efforts in medical R&D with emphasis on infectious diseases, blood products, diving medicine and chemical defense.
Buenos Aires, Argentina
Blood Product Safety and Preservation.
US-Argentina IEA
115+ Years of X-rays in Medicine and Biology.
Grand Rounds, Good Samaritan Hospital, Baltimore, MD
100+ Years of X-rays in Medicine and Biology.
Multiple locations, 2007
Update on Breast Cancer.
Management Conference, WRAMC, Washington, D.C
Breast-Ovarian Cancer Syndromes.
Grand Rounds, WRAMC, Washington, D.C
The Surgical Patient with Thrombocytopenia – How I Treat.
Management Conference, WRAMC, Washington, D.C
Warfarin Resistance.
Grand Rounds, WRAMC, Washington, D.C
Forward Resuscitative Surgical Capability.
XXXV Congress International Committee of Military Medicine, Crystal City, VA
Hemoglobin Bases Oxygen Carriers.
America’s Blood Centers, Sarasota, FL
Improvements in Combat Casualty Care & Approach to Thrombosis and Hemostasis.
European Regional Medical Command, Bad Kissingen, Germany
Improved Hemorrhage Control and Management.
Battlefield Healthcare, Alexandria, VA
Hypercoaguable States.
American College of Rheumatology
Oxygen Therapeutics.
United States Pharmacopoeia, Rockville, MD
Military Blood Requirements.
American Society for Artificial Internal Organs, Washington, D.C
Physical and thermal properties of blood storage bags: Implications for freezing – Recent experience with red blood cell storage.
National Capitol Area Transfusion Medicine, Holy Cross Hospital, Silver Spring, MD
Physical and thermal properties of blood storage bags: Implications for freezing.
Multiple locations, 2001, 2002
Bleeding Disorders and Hypercoaguable States.
ACP-ASIM Sponsored Board Review Course Georgetown University; Washington, D.C.
Freeze-Dried Human Blood Plasma: Far Forward Deployment and Use as a Resuscitation Fluid.
Cerus Corporation; Concord CA
Plas+SD (Solvent Detergent treated plasma), Clinical Experience and New Directions.
American Red Cross; Portland, OR
In Vivo Efficacy of Platelets.
FDA/DoD Symposium
Platelet Substitutes – Where are We Now?
Greater New York Council of Blood Banks
Assessment of Platelet Membrane Integrity during Storage.
Society for Cryobiology
Methods to Assess Platelet Function.
Society for Cryobiology
Join now to see all

Other

A Quantitative Method for Measuring Thrombin Time for Determining Plasma Levels of Thrombin Specific Inhibitors.
Reid TJ, U.S. Application No. 07/893,63 1
Fibrinogen Bandages and Arterial Bleeding Models and Methods of Making and Using.
Reid TJ, Patent Number 6,891,077

Professional Memberships

American College of Physicians - ACP
Fellow
American Society of Hematology - ASH
Member
American Society of Clinical Oncology - ASCO
Member
American Medical Association - AMA
Member